Mainz Biomed NV Stock Price, News & Analysis
Why is QUCY Stock Down Today?
Company Description
Mainz Biomed NV (NASDAQ: QUCY) is a publicly traded diagnostics & research company in the Healthcare sector. The company has a market capitalization of $7.4M, ranking #6,541 among all listed U.S. companies by market cap.
QUCY stock has declined 30.5% over the past year. Shares last traded at $0.5270.
This page provides a comprehensive overview of QUCY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Mainz Biomed NV (QUCY) stock last traded at $0.5270, down 14.70% from the previous close. Over the past 12 months, the stock has lost 30.5%. At a market capitalization of $7.4M, QUCY is classified as a micro-cap stock with approximately 9.1M shares outstanding.
Latest News
Mainz Biomed NV has 2 recent news articles, with the latest published 6 days ago. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. View all QUCY news →
SEC Filings
Financial Highlights
Upcoming Events
Shareholder meeting for name change
Mainz Biomed NV has 1 upcoming scheduled event. The next event, "Shareholder meeting for name change", is scheduled for April 1, 2026 (in 9 days). Investors can track these dates to stay informed about potential catalysts that may affect the QUCY stock price.
Short Interest History
Days to Cover History
QUCY Company Profile & Sector Positioning
Mainz Biomed NV (QUCY) operates in the Diagnostics & Research industry within the broader Healthcare sector and is listed on the NASDAQ.